Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

MRI scans may reveal hidden clues to premature ejaculation

NCT ID NCT07614854

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study will examine whether the size and shape of the prostatic urethra and seminal vesicles, as seen on prostate MRI, are linked to premature ejaculation (PE) severity. Researchers will compare 150 men with and without PE, all already scheduled for an MRI. Participants will fill out questionnaires and provide a blood sample. The goal is to identify anatomical features that may contribute to PE, which could inform future research.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors understand whether physical features of the prostate and seminal vesicles contribute to premature ejaculation, potentially guiding future treatments.
What could go wrong
This is an early observational study, not a treatment trial. It only looks for associations, so it cannot prove cause and effect. Results may not lead to any direct changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

* Any major psychiatric or somatic disorder * Hormonal disorders such as hypothyroidism or hyperthyroidism * Erectile dysfunction (IIEF-15 erectile function domain score \<26) * Age below 18 or above 55 years

Ages

18 to 55 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \- Male aged 18 to 55 years * In a stable, heterosexual, monogamous relationship with the same female partner for at least 6 months * Normal erectile function defined as IIEF-15 erectile function domain score ≥26 * Scheduled for clinically indicated multiparametric prostate MRI due to elevated PSA or hematospermia * Not using any medication that may affect sexual function or psychological status (e.g., SSRIs, PDE5 inhibitors) Exclusion Criteria: * Any major psychiatric or somatic disorder * Hormonal disorders such as hypothyroidism or hyperthyroidism * Erectile dysfunction (IIEF-15 erectile function domain score \<26) * Age below 18 or above 55 years

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ejaculation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Başakşehir Çam and Sakura City Hospital, Department of Urology

    Istanbul, Istanbul, 34200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.